>

Thomas Hurwich - AbbVie Vice President Controller

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:3em;padding-top: 40px;;'>ABB</div>
ABBV -- USA Stock  

Fiscal Quarter End: March 31, 2020  

  President
Mr. Thomas A. Hurwich is no longer Vice President, Controller of the Company, effective February 28, 2017. He served as Abbott Vice President, Internal Audit from 2009 to 2012, and as Divisional Vice President, Controller, Abbott Diagnostics Division from 2003 to 2009.
Age: 54  President Since 2013      
847 932-7900  www.abbvie.com

Thomas Hurwich Latest Insider Activity

Thomas Hurwich over three months ago via Macroaxis 
AbbVie exotic insider transaction detected

Management Efficiency

The company currently holds 38.84 B in liabilities with Debt to Equity (D/E) ratio of 9.53 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie has Current Ratio of 1.13 suggesting that it is in a questionable position to pay out its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Karen LingAllergan Plc
2014
Daniel SkovronskyEli Lilly And Company
2018
David FredricksonAstrazeneca PLC
2017
Francis CussBristol Myers Squibb Company
2013
Mikael DolstenPfizer
2010
Robert StewartAllergan Plc
N/A
Jennifer ZacharyMerck Company
2018
Iskra ReicAstrazeneca PLC
2017
Johna NortonEli Lilly And Company
2017
Regis SimardGlaxoSmithKline PLC
2018
Myles ONeillEli Lilly And Company
2018
Ann JudgeBristol Myers Squibb Company
2016
Rady JohnsonPfizer
2013
Sally SusmanPfizer
2010
Ashley WatsonMerck Company
2015
Aarti ShahEli Lilly And Company
2018
Abbas HussainGlaxoSmithKline PLC
2014
Roger PerlmutterMerck Company
2013
Jonathon KellermanAllergan Plc
2014
Joseph WolkJohnson Johnson
2018
Paul CarterGilead Sciences
2014

Company Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. AbbVie operates under Drug Manufacturers - General classification in USA and is traded on BATS Exchange.AbbVie (ABBV) is traded on BATS Exchange in USA. It is located in 1 North Waukegan Road, North Chicago, IL 60064-6400, United States and employs 30,000 people. AbbVie is listed under Pharmaceutical Products category by Fama And French industry classification.

AbbVie Leadership Team

Richard Gonzalez, Chairman, CEO and Chairman of Executive CommitteeView
Brian Durkin, Vice President ControllerView
Thomas Hurwich, Vice President ControllerView
Frederick Waddell, Independent DirectorView
Robert Alpern, Independent DirectorView
Glenn Tilton, Independent DirectorView
Carlos Alban, Executive VP of Commercial OperationsView
Robert Michael, Vice President ControllerView
Henry Gosebruch, Executive Vice President Chief Strategy OfficerView
Jeffrey Stewart, Senior Vice President U.S. Commercial OperationsView
Rebecca Roberts, Independent DirectorView
Edward Liddy, Independent DirectorView
Brett Hart, Independent DirectorView
William Chase, CFO and Executive VPView
William Burnside, Independent DirectorView
Roxanne Austin, Independent DirectorView
Timothy Richmond, Sr. VP of HRView
Nicholas Donoghoe, Senior Vice President - Enterprise InnovationView
Laura Schumacher, Executive VP of Bus. Devel. and External Affairs, General Counsel and Corporate SecretaryView
Roy Roberts, Independent DirectorView
Michael Severino, Executive Vice President - Research & Development, Chief Scientific OfficerView
Azita SalekiGerhardt, Senior Vice President - OperationsView
Edward Rapp, Independent DirectorView
Melody Meyer, DirectorView

Stock Performance Indicators

Current Sentiment - ABBV

AbbVie Investor Sentiment

Majority of Macroaxis users are presently bullish on AbbVie. What is your sentiment towards investing in AbbVie? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

AbbVie Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for AbbVie and Johnson Johnson. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to Trending Equities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.